LORA CROWLEY: Open Payments
NPI 1932207511 · DOYLESTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,159 in 91 payments from 17 companies in 2025. Trend: 2023 $1,297 · 2024 $1,797 · 2025 $2,159
Food & beverage: $1,959Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 14 | $381 |
| HARMONY BIOSCIENCES LLC | 8 | $301 |
| Regeneron Healthcare Solutions, Inc. | 17 | $216 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $200 |
| AstraZeneca Pharmaceuticals LP | 10 | $187 |
| GENZYME CORPORATION | 8 | $156 |
| Insmed, Inc. | 7 | $136 |
| Verona Pharma, Inc. | 4 | $110 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $100 |
| Electromed, Inc. | 7 | $100 |
Products named: DUPIXENT, WAKIX, NUCALA, LUMRYZ, TRELEGY ELLIPTA, AIRSUPRA, Ohtuvayre, Arikayce.
Industry payments across PA — which companies pay providers there.
